These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6279526)

  • 1. Complement-fixing antibody to Epstein-Barr virus soluble antigen in populations at high and low risk for nasopharyngeal carcinoma.
    Levine PH; Ebbesen P; Connelly RR; Das S; Middleton M; Mestre M
    Int J Cancer; 1982 Mar; 29(3):265-8. PubMed ID: 6279526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma.
    Melbye M; Ebbesen P; Levine PH; Bennike T
    Int J Cancer; 1984 Nov; 34(5):619-23. PubMed ID: 6094363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On Epstein-Barr virus (EBV) infection in Greenland Eskimos, Danes in Greenland, and Danes in Denmark.
    Melbye M; Ebbesen P; Levine PH
    Arch Geschwulstforsch; 1983; 53(3):261-5. PubMed ID: 6311139
    [No Abstract]   [Full Text] [Related]  

  • 4. Danish children in Greenland have high Epstein-Barr virus titers.
    Ebbesen P; Melbye M; Levine PH; Andersen HK
    Infect Immun; 1983 Jul; 41(1):418-9. PubMed ID: 6305845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.
    Saemundsen AK; Albeck H; Hansen JP; Nielsen NH; Anvret M; Henle W; Henle G; Thomsen KA; Kristensen HK; Klein G
    Br J Cancer; 1982 Nov; 46(5):721-8. PubMed ID: 6293523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
    Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T
    Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.
    Dardari R; Khyatti M; Benider A; Jouhadi H; Kahlain A; Cochet C; Mansouri A; El Gueddari B; Benslimane A; Joab I
    Int J Cancer; 2000 Apr; 86(1):71-5. PubMed ID: 10728597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
    Hsu MM; Chen JY; Chen CJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721
    [No Abstract]   [Full Text] [Related]  

  • 10. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
    Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious mononucleosis in Greenland: a disease of the non-indigenous population.
    Melbye M; Ebbesen P; Bennike T
    Scand J Infect Dis; 1984; 16(1):9-15. PubMed ID: 6695160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
    Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
    Cevenini R; Donati M; Caliceti U; Moroni A; Tamba I; Rumpianesi F
    J Infect; 1986 Mar; 12(2):127-31. PubMed ID: 3009628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
    Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
    J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
    Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
    Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
    J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX; Zeng Y; Wolf H
    Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.